FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2061034345> ?p ?o ?g. }

• W2061034345 endingPage "191" @default.
• W2061034345 startingPage "183" @default.
• W2061034345 abstract "We have previously shown that laminin-8, a vascular basement membrane component, was overexpressed in human glioblastomas multiforme and their adjacent tissues compared to normal brain. Increased laminin-8 correlated with shorter glioblastoma recurrence time and poor patient survival making it a potential marker for glioblastoma diagnostics and prediction of disease outcome. However, laminin-8 therapeutic potential was unknown because the technology of blocking the expression of multi-chain complex proteins was not yet developed. To inhibit the expression of laminin-8 constituents in glioblastoma in vitro and in vivo, we used Polycefin, a bioconjugate drug delivery system based on slime-mold Physarum polycephalum-derived poly(malic acid). It carries an attached transferrin receptor antibody to target tumor cells and to deliver two conjugated morpholino antisense oligonucleotides against laminin-8 α4 and β1 chains. Polycefin efficiently inhibited the expression of both laminin-8 chains by cultured glioblastoma cells. Intracranial Polycefin treatment of human U87MG glioblastoma-bearing nude rats reduced incorporation of both tumor-derived laminin-8 chains into vascular basement membranes. Polycefin was thus able to simultaneously inhibit the expression of two different chains of a complex protein. The treatment also significantly reduced tumor microvessel density (p < 0.001) and area (p < 0.001) and increased animal survival (p < 0.0004). These data suggest that laminin-8 may be important for glioblastoma angiogenesis. Polycefin, a versatile nanoscale drug delivery system, was suitable for in vivo delivery of two antisense oligonucleotides to brain tumor cells causing a reduction of glioblastoma angiogenesis and an increase of animal survival. This system may hold promise for future clinical applications." @default.
• W2061034345 created "2016-06-24" @default.
• W2061034345 creator A5014932947 @default.
• W2061034345 creator A5019253871 @default.
• W2061034345 creator A5021159504 @default.
• W2061034345 creator A5022218689 @default.
• W2061034345 creator A5039833815 @default.
• W2061034345 creator A5062632023 @default.
• W2061034345 creator A5067103220 @default.
• W2061034345 creator A5069211990 @default.
• W2061034345 date "2006-11-16" @default.
• W2061034345 modified "2023-10-11" @default.
• W2061034345 title "Inhibition of laminin-8 in vivo using a novel poly(malic acid)-based carrier reduces glioma angiogenesis" @default.
• W2061034345 cites W1507857939 @default.
• W2061034345 cites W1537872578 @default.
• W2061034345 cites W1552188497 @default.
• W2061034345 cites W1601529652 @default.
• W2061034345 cites W1736564208 @default.
• W2061034345 cites W1813936612 @default.
• W2061034345 cites W1839329789 @default.
• W2061034345 cites W1966882402 @default.
• W2061034345 cites W1975429911 @default.
• W2061034345 cites W1982117125 @default.
• W2061034345 cites W1985040758 @default.
• W2061034345 cites W2010116355 @default.
• W2061034345 cites W2013749488 @default.
• W2061034345 cites W2016644327 @default.
• W2061034345 cites W2017753576 @default.
• W2061034345 cites W2030855909 @default.
• W2061034345 cites W2034464848 @default.
• W2061034345 cites W2044030495 @default.
• W2061034345 cites W2047710667 @default.
• W2061034345 cites W2049640224 @default.
• W2061034345 cites W2054717287 @default.
• W2061034345 cites W2071612697 @default.
• W2061034345 cites W2071635215 @default.
• W2061034345 cites W2077000491 @default.
• W2061034345 cites W2084740377 @default.
• W2061034345 cites W2115899432 @default.
• W2061034345 cites W2120465728 @default.
• W2061034345 cites W2123975659 @default.
• W2061034345 cites W2134077476 @default.
• W2061034345 cites W2145832431 @default.
• W2061034345 cites W2147810986 @default.
• W2061034345 cites W2152029916 @default.
• W2061034345 cites W2166415547 @default.
• W2061034345 cites W2168339179 @default.
• W2061034345 cites W2169965478 @default.
• W2061034345 cites W227275829 @default.
• W2061034345 cites W83133541 @default.
• W2061034345 doi "https://doi.org/10.1007/s10456-006-9046-9" @default.
• W2061034345 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3487708" @default.
• W2061034345 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17109197" @default.
• W2061034345 hasPublicationYear "2006" @default.
• W2061034345 type Work @default.
• W2061034345 sameAs 2061034345 @default.
• W2061034345 citedByCount "52" @default.
• W2061034345 countsByYear W20610343452012 @default.
• W2061034345 countsByYear W20610343452013 @default.
• W2061034345 countsByYear W20610343452014 @default.
• W2061034345 countsByYear W20610343452016 @default.
• W2061034345 countsByYear W20610343452017 @default.
• W2061034345 countsByYear W20610343452019 @default.
• W2061034345 countsByYear W20610343452020 @default.
• W2061034345 countsByYear W20610343452021 @default.
• W2061034345 crossrefType "journal-article" @default.
• W2061034345 hasAuthorship W2061034345A5014932947 @default.
• W2061034345 hasAuthorship W2061034345A5019253871 @default.
• W2061034345 hasAuthorship W2061034345A5021159504 @default.
• W2061034345 hasAuthorship W2061034345A5022218689 @default.
• W2061034345 hasAuthorship W2061034345A5039833815 @default.
• W2061034345 hasAuthorship W2061034345A5062632023 @default.
• W2061034345 hasAuthorship W2061034345A5067103220 @default.
• W2061034345 hasAuthorship W2061034345A5069211990 @default.
• W2061034345 hasBestOaLocation W20610343452 @default.
• W2061034345 hasConcept C150903083 @default.
• W2061034345 hasConcept C153911025 @default.
• W2061034345 hasConcept C185592680 @default.
• W2061034345 hasConcept C189165786 @default.
• W2061034345 hasConcept C202751555 @default.
• W2061034345 hasConcept C207001950 @default.
• W2061034345 hasConcept C2776193487 @default.
• W2061034345 hasConcept C2778227246 @default.
• W2061034345 hasConcept C2778271429 @default.
• W2061034345 hasConcept C2779814568 @default.
• W2061034345 hasConcept C2780394083 @default.
• W2061034345 hasConcept C502942594 @default.
• W2061034345 hasConcept C55493867 @default.
• W2061034345 hasConcept C86803240 @default.
• W2061034345 hasConcept C95444343 @default.
• W2061034345 hasConceptScore W2061034345C150903083 @default.
• W2061034345 hasConceptScore W2061034345C153911025 @default.
• W2061034345 hasConceptScore W2061034345C185592680 @default.
• W2061034345 hasConceptScore W2061034345C189165786 @default.
• W2061034345 hasConceptScore W2061034345C202751555 @default.
• W2061034345 hasConceptScore W2061034345C207001950 @default.
• W2061034345 hasConceptScore W2061034345C2776193487 @default.
• W2061034345 hasConceptScore W2061034345C2778227246 @default.

• next